insider24.ch
Back to the feed

Shareholding disclosure

HBM BioVentures Ltd. Cayman

inBasilea Pharmaceutica AG, Allschwil

Declared position

4.72%

Threshold

Crossed downwards

Timeline

Published

07.01.2008

Transaction

21.12.2007

Transfer date

21.12.2007

Voting rights breakdown

Voting rights acquired3.67%
Voting rights sold4.72%
Below threshold0%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T5547D5307

Beneficial owner

HBM BioVentures Ltd. Cayman

Declared address

HBM BioVentures Ltd. (Cayman), George Town, Grand Cayman

Beteiligungspapiere Namenaktien Anzahl Stimmrechte Anzahl in % 336 343 336 343 3,67 Wandel-, Erwerbs- und eingeräumte Veräusserungsrechte Art der Rechte Anzahl Damit verbundene Stimmrechte Anzahl in % Call-Option 22 600 000 282 500 3,08 BSLDU SW; ISIN: CH0028814678 Pull-Option 150 000 150 000 1,64 DB-BSLN; Put-Option, welche der Deutschen Bank eingeräumt wurde; Basiswert: Basilea Pharmaceutica Namenaktien (BSLN); Ratio: 1:1; Strike Price: CHF 240.-; Ablauf: 20. März 2008; Art: European Style

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open